Breaking News

rfxcel Awarded ISO 9001:2015 Certification

The company demonstrated its long-standing commitment to quality management and processes and was officially certified ...

Oxford BioDynamics signs fifth collaboration agreement in immuno-oncology space

The company will use its EpiSwitch platform to offer high resolution mapping of epigenetic profiles in patients

Non-small cell lung cancer market projected to be worth $14.6 billion by 2024

Following the recent spate of approvals in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), ...

Biocontainment facilities: Down the drain

Graham Scarr, Technical Director of AstellBio, discusses approaches to effluent decontamination in containment level 2 ...

US FDA awards Certara’s Simcyp Division two new dermal virtual bioequivalence grants

New grants support FDA’s GDUFA priorities of expanding bioequivalence methods for topical dermatological products and ...

£500,000 grant could lead to a new class of antibiotics to combat superbugs

A new antibiotic, hailed as the “last line of defence” in the battle against drug-resistant superbugs such as MSRA and ...

Serialisation and data connectivity: Part II

The new wrinkle in your supply chain, click here to read part I

ADC Bio secures additional equity round investment

Extra funding for strategic move into downstream formulation, fill-finish capabilities and full exploitation of Lock- ...

Crown Bioscience expands cardiovascular and metabolic disease research capability

The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana

Low touch machine learning

A new asset control solution

Serialisation and data connectivity: Part I

The new wrinkle in your supply chain

Extraction as a science

Custom development and manufacturing has traditionally been part of Indena’s strategy and offering

Ardena cements growth and expansion with new HQ

It now operates across six sites in Belgium, the Netherlands, Sweden and Latvia and boasts a global reach, servicing ...

Global glioblastoma market set to reach $1.4bn by 2027

GlobalData’s latest report states that a drive to address the high level of unmet needs will be hindered by ...